Novonesis (Novozymes) A/S (NSIS-B) — Capital Reinvestment Ratio
Novonesis (Novozymes) A/S (NSIS-B) has a Capital Reinvestment Ratio of 0.47x as of March 2026, meaning it reinvests 0% of its operating cash flow (Dkr167.06 Million) in capital expenditures (Dkr79.08 Million). Check tangible net worth ratio of Novonesis (Novozymes) A/S to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Novonesis (Novozymes) A/S Capital Reinvestment Ratio (2002–2025)
This chart tracks Novonesis (Novozymes) A/S's Capital Reinvestment Ratio across 24 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Novonesis (Novozymes) A/S.
Annual Capital Reinvestment Ratio for Novonesis (Novozymes) A/S (2002–2025)
Year-by-year Capital Reinvestment Ratio for Novonesis (Novozymes) A/S from 2002 to 2025. See NSIS-B FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | Dkr1.22 Billion | Dkr470.80 Million | ▲ +9.3% |
| 2024 | 0.35x | Dkr1.02 Billion | Dkr359.80 Million | ▼ -28.8% |
| 2023 | 0.50x | Dkr4.15 Billion | Dkr2.06 Billion | ▼ -31.4% |
| 2022 | 0.72x | Dkr4.01 Billion | Dkr2.89 Billion | ▲ +136.3% |
| 2021 | 0.31x | Dkr4.06 Billion | Dkr1.24 Billion | ▲ +41.4% |
| 2020 | 0.22x | Dkr4.36 Billion | Dkr940.00 Million | ▼ -20.0% |
| 2019 | 0.27x | Dkr3.20 Billion | Dkr862.00 Million | ▼ -25.5% |
| 2018 | 0.36x | Dkr3.68 Billion | Dkr1.33 Billion | ▼ -7.7% |
| 2017 | 0.39x | Dkr4.06 Billion | Dkr1.59 Billion | ▲ +39.9% |
| 2016 | 0.28x | Dkr3.84 Billion | Dkr1.08 Billion | ▼ -3.3% |
| 2015 | 0.29x | Dkr3.34 Billion | Dkr968.00 Million | ▲ +86.6% |
| 2014 | 0.16x | Dkr4.53 Billion | Dkr703.00 Million | ▼ -47.0% |
| 2013 | 0.29x | Dkr2.60 Billion | Dkr762.00 Million | ▼ -31.6% |
| 2012 | 0.43x | Dkr2.76 Billion | Dkr1.18 Billion | ▼ -12.3% |
| 2011 | 0.49x | Dkr2.71 Billion | Dkr1.32 Billion | ▼ -14.5% |
| 2010 | 0.57x | Dkr2.32 Billion | Dkr1.33 Billion | ▲ +1.9% |
| 2009 | 0.56x | Dkr1.82 Billion | Dkr1.02 Billion | ▼ -0.7% |
| 2008 | 0.57x | Dkr1.70 Billion | Dkr959.00 Million | ▲ +30.4% |
| 2007 | 0.43x | Dkr1.71 Billion | Dkr743.00 Million | ▲ +31.7% |
| 2006 | 0.33x | Dkr1.53 Billion | Dkr505.00 Million | ▲ +19.3% |
| 2005 | 0.28x | Dkr1.33 Billion | Dkr366.00 Million | ▲ +6.0% |
| 2004 | 0.26x | Dkr1.29 Billion | Dkr335.00 Million | ▼ -10.1% |
| 2003 | 0.29x | Dkr1.37 Billion | Dkr398.00 Million | ▼ -6.8% |
| 2002 | 0.31x | Dkr1.18 Billion | Dkr367.00 Million | — |